Not Yet RecruitingNot Applicable

Characterization of Abdomino-pelvic Lesions by 18Fluorine- Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography

79 participantsStarted 2025-08

Plain-language summary

The aim of the study is to identify and characterize lesions in the abdominopelvic region detected by 18fluorine- fluorodeoxyglucose (FDG) positron Emission Tomography combined Computed Tomography (PET/CT) scan, including determining their malignant or benign nature, and to determine the extent of disease to facilitate proper management

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Inclusion criteria: All of the patients were suspected of having malignancy (new, recurrent or metastatic) based on pathology or conventional radiological studies and were referred to nuclear medicine unit for 18F-FDG-PET-CT scan Exclusion Criteria: * patients underwent recent abdominal or pelvic surgery. * patients with blood glucose level ˃200 mg/dL * Pregnancy

What they're measuring

Evaluate the performance of 18F FDG PET/CT

Timeframe: 3 years

Trial details

NCT IDNCT07127627

SponsorAssiut University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2028-10

Contact for this trial

salma A samy, ass. lecturer

01069720261 salmasamy95@aun.edu.eg

View on ClinicalTrials.gov More Abdominal Sepsis trials